Cue Biopharma EV 2011-2025 | CUE

EV Jährlich Cue Biopharma

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
43.5 M	62.4 M	82.4 M	307 M	334 M	309 M	112 M	317 M	1.1 M	376 K	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
334 M	376 K	157 M

EV anderer Aktien in der Pharmaeinzelhändler

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
AC Immune SA ACIU	82.4 M	$ 2.8	2.19 %	$ 229 M	Schweiz
ADiTx Therapeutics ADTX	23.1 M	$ 2.49	-11.39 %	$ 32.8 K	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
Abeona Therapeutics ABEO	184 M	$ 4.59	-4.08 %	$ 98.1 M	USA
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Amneal Pharmaceuticals AMRX	1.72 B	$ 12.12	-1.58 %	$ 3.74 B	USA
Axcella Health AXLA	22.6 M	-	-16.42 %	$ 249 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Armata Pharmaceuticals ARMP	250 M	$ 5.37	-20.68 %	$ 194 M	USA
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA
Brainstorm Cell Therapeutics BCLI	15.7 M	-	-2.5 %	$ 5.88 M	USA
argenx SE ARGX	-796 M	$ 919.62	2.76 %	$ 25 B	Niderland
Ascendis Pharma A/S ASND	726 M	$ 203.0	-3.72 %	$ 5 B	Danmark
Achieve Life Sciences ACHV	95.5 M	$ 4.64	-0.32 %	$ 92 M	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	253 B	-	0.49 %	$ 251 B	Cayman-islands
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Alterity Therapeutics Limited ATHE	-28.9 M	$ 3.36	2.73 %	$ 8.08 B	Australia
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Bellerophon Therapeutics BLPH	77.1 M	-	-74.18 %	$ 955 K	USA
BioLineRx Ltd. BLRX	15 M	$ 3.29	-1.5 %	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	13.5 B	$ 54.27	-1.38 %	$ 10.3 B	USA
Adaptimmune Therapeutics plc ADAP	2.15 B	-	-15.15 %	$ 60.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Baudax Bio BXRX	29.8 M	-	0.59 %	$ 63 K	USA
AbbVie ABBV	337 B	$ 224.99	-0.01 %	$ 398 B	USA
Cara Therapeutics CARA	71.1 M	-	-3.03 %	$ 260 M	USA
CymaBay Therapeutics CBAY	3.36 B	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	91.4 M	-	-	$ 3.74 B	USA
BioNTech SE BNTX	-6.64 B	$ 96.22	-1.21 %	$ 27.2 B	Germany
Codiak BioSciences CDAK	281 M	-	-55.98 %	$ 2.15 M	USA
Adaptive Biotechnologies Corporation ADPT	1.47 B	$ 18.75	-0.48 %	$ 2.76 B	USA
Avid Bioservices CDMO	661 M	-	-	$ 789 M	USA
BioXcel Therapeutics BTAI	107 M	$ 1.92	-7.01 %	$ 4.87 M	USA
Biogen BIIB	28.3 B	$ 179.76	1.11 %	$ 26.2 B	USA
Cerevel Therapeutics Holdings CERE	6.84 B	-	-	$ 7.29 B	USA
ContraFect Corporation CFRX	24.7 M	-	-5.16 %	$ 5.39 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Beam Therapeutics BEAM	2.59 B	$ 23.52	-2.22 %	$ 1.94 B	USA
AbCellera Biologics ABCL	1.01 B	$ 3.45	-0.72 %	$ 1.02 B	Canada
Cabaletta Bio CABA	-155 M	$ 2.37	-2.67 %	$ 2.77 M	USA
Clearside Biomedical CLSD	122 M	-	-	$ 25.3 M	USA
Celsion Corporation CLSN	20.7 M	-	-6.63 %	$ 13.9 M	USA
Clovis Oncology CLVS	839 M	-	-7.23 %	$ 13 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Checkmate Pharmaceuticals CMPI	11.4 M	-	-	$ 231 M	USA
Chimerix CMRX	95.8 M	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	14.7 M	-	-	$ 401 M	USA